Detalhe da pesquisa
1.
Shortened 8 Weeks Course of Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients, With Chronic Hepatitis C Infection.
J Pediatr Gastroenterol Nutr
; 66(3): 425-427, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29135824
2.
Sustained Viral Response in Genotype 4 Chronic Hepatitis C Virus-infected Children and Adolescents Treated With Sofosbuvir/Ledipasvir.
J Pediatr Gastroenterol Nutr
; 67(5): 626-630, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30216203
3.
Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection.
J Pediatr Gastroenterol Nutr
; 67(1): 86-89, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29570560
4.
Meeting Reports: Adolescence - a Transition to Adulthood Proceedings of the 24th Aschauer Soiree, held at Jurata, Poland, November 5th 2016.
Pediatr Endocrinol Rev
; 14(3): 326-334, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28508603
5.
Treatment of Chronic Hepatitis C in Adolescent Patients With Positive HBsAg or With Occult Hepatitis B: Is the Risk of Hepatitis B Reactivation Significant?
Pediatr Infect Dis J
; 40(1): 11-15, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925546
6.
Effects of Dual Sofosbuvir/Daclatasvir Therapy on Weight and Linear Growth in Adolescent Patients with Chronic Hepatitis C Virus Infection.
Pediatr Infect Dis J
; 38(7): e154-e157, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31194713
7.
Effectiveness of 8-week sofosbuvir/ledipasvir in the adolescent chronic hepatitis C-infected patients.
Eur J Gastroenterol Hepatol
; 31(8): 1004-1009, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30676473